Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

JIU-JITSU WITH MISINFORMATION IN THE AGE OF COVID: USING REFUTATION-BASED LEARNING TO ENHANCE VACCINE UPTAKE AND KNOWLEDGE AMONG HEALTHCARE PROFESSIONALS AND THE PUBLIC

Project description

Vaccinating against misconceptions to protect global public health

Despite the unquestionable success of immunisation in reducing and eliminating infectious diseases, scepticism on information about vaccine efficacy and safety remains a universal menace. According to the World Health Organisation, the diffusion of mistrust is due to misinformation provided by the internet. To address the challenging vaccine hesitancy, the EU-funded JITSUVAX project aims at utilising the very misinformation about vaccinations. By training health care professionals through inoculation and refutational learning and enabling them to communicate more constructively with patients, the project aspires to contribute to the increase of public confidence in immunisation.

Objective

Vaccine hesitancy—the delay or refusal of vaccination without medical indication—has been cited as a serious threat to global health by the World Health Organization (WHO), attributing it to misinformation on the internet. The WHO has also identified Health Care Professionals (HCPs) as the most trusted influencers of vaccination decisions.
JITSUVAX leverages those insights to turn toxic misinformation into a potential asset based on two premises: 1. The best way to acquire knowledge and to combat misperceptions is by employing misinformation itself, either in weakened doses as a cognitive “vaccine”, or through thorough analysis of misinformation during “refutational learning”. 2. HCPs form the critical link between vaccination policies and vaccine uptake.
The principal objective of JITSUVAX is to leverage misinformation about vaccinations into an opportunity by training HCPs through inoculation and refutational learning, thereby neutralizing misinformation among HCPs and enabling them to communicate more effectively with patients. JITSUVAX comprises 4 scientific work packages (WPs 1-4), plus one Management WP (WP0).
WP1 will systematically measure HCP attitudes towards vaccinations across participating countries.
WP2 will analyse argumentation by anti-vaccination activists to provide material for inoculation and refutational learning. WP2 will also develop novel tools that improve public resilience to misinformation and HCP’s knowledge and attitudes concerning vaccinations.
WP3 will translate the findings from WP1 and WP2 into practice, by exploring several new tools, ranging from a new “empathic refutational interview” to interventions in the training of HCPs.
WP4 focuses on impact and dissemination. WP4 will design and develop a guidance document for HCPs and public health bodies. Through the team’s contacts and previous collaborations with WHO and UNICEF, we will disseminate and leverage our new knowledge for global impact.

Call for proposal

H2020-SC1-BHC-2018-2020

See other projects for this call

Sub call

H2020-SC1-2020-Single-Stage-RTD

Coordinator

UNIVERSITY OF BRISTOL
Net EU contribution
€ 1 134 894,74
Address
BEACON HOUSE QUEENS ROAD
BS8 1QU Bristol
United Kingdom

See on map

Region
South West (England) Gloucestershire, Wiltshire and Bristol/Bath area Bristol, City of
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 134 894,74

Participants (6)